It was thought that AJ Jewell's death was from being beaten to death in a fight. Now there is some possibility that Sickle Cell Anemia could have played a factor in his death.

A symptomless blood disorder, monoclonal gammopathy of undetermined significance, known as MGUS, is not linked to as many serious diseases as previously thought. This finding may save patients from undergoing unnecessary workup and treatment according to a study published in the August 2009 issue of Mayo Clinic Proceedings.

Patients suffering from a blood disorder that prevents proper clotting have the option of a new medication that may dramatically improve their health.

Researchers have identified a gene that directly affects the production of a form of hemoglobin that is instrumental in modifying the severity of the inherited blood disorders sickle cell disease and thalassemia.

A unique partnership between industry and academia has led to human clinical trials of a new drug for a rare class of blood diseases called myeloproliferative disorders (MPD), which are all driven by the same genetic mutation and can evolve into leukemia.

Researchers have moved a step closer to understanding why alpha-thalassaemia, an inherited blood disorder, appears to offer protection against severe malarial anaemia. The key appears to be in the abnormally large number of small red blood cells which characterises thalassaemia.

Mayo Clinic researchers today reported the discovery of a link between erythropoiesis-stimulating agents (ESAs) and leukemic transformation (conversion to leukemia) of the blood disorder myelofibrosis.

Sickle cell disease (SCD) is an inherited blood disorder caused by a genetic mutation that leads to the generation of a mutant form of the beta-globin chain of hemoglobin (Hb).